Venturepharm is a HK  public listed company (8225).,it is a leading fully-integrated specialty pharmaceutical power house based in China. The Company is also a global service provider of API and formulation development, clinical trial, product registration, sales and marketing to pharmaceutical and biotechnology companies in China market and beyond.

VP API's (Venturepharm API) core competency focuses on its strong R&D capacity, driven by over two hundred chemical elites from all over the world. we are able to offer about 50 bulk active pharmaceutical ingredients and relative key intermediates. We have 2 bulk API manufacturing facilities, one of which is cGMP approved & USFDA inspected.
 
Our expertise in organic synthesis, process development and a controlled supply chain and 20 patents application annually enables us to provide the demanding customers Bulk APIs with high quality and competitive price.

We are aggressively building our product portfolio to cater to the generic and patent-challenged formulators in regulated markets, and the generic players in emerging markets. Today, Venturepharm API has a world-wide clientele of 60 companies engaging in various kinds of activities including technology licensing and marketing joint venture.

With the strong background of R&D capacity and GMP manufacturing facilities, we are also among the largest R&D services providers.